Mesenchymal stromal cells (MSC) are a promising source for cell-based therapies as they secrete a myriad of reparative factors in response to inflammatory stimuli. In this study, multilayers of heparin and collagen (HEP/COL) were used as a bioactive surface coating to enhance human MSC (hMSC) response to soluble interferon-gamma (IFN-γ). Multilayers were formed, via layer-by-layer assembly, varying the final layer between COL and HEP and supplemented with IFN-γ in the culture medium. hMSC adhesion, proliferation, and cytokine expression were assessed. Infrared variable angle spectroscopic ellipsometry confirmed film chemistry, thickness, and roughness. COL-ending films of 12 layers of HEP/COL had an average thickness of 129 ± 5.8 nm, and 13 layers (HEP-ending) were 178 ± 28.3 nm thick. Changes in temperature between 25-37 °C did not have significant effects on film chemistry, thickness, or roughness. An EdU incorporation assay revealed that IFN-γ had an antiproliferative effect in all conditions evaluated except when hMSCs were cultured on HEP-ending films supplemented with IFN-γ. Moreover, hMSCs cultured on HEP-ending films supplemented with IFN-γ had a higher cytokine expression as compared with cells cultured on tissue culture polystyrene, COL-ending films with and without IFN-γ, and HEP-ending films without IFN-γ as measured by Luminex assay. Finally, immunostaining revealed strong integrin binding and FAK phosphorylation for each condition. This study shows that HEP/COL films can modulate hMSC response to soluble factors, which may be exploited in cell manufacturing practices.
No takes yet. Share an insight, caveat, or question.
Castilla‐Casadiego et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: